No Data
No Data
No Data
No Data
No Data
PTC Therapeutics to Participate at Upcoming Investor Conferences
WARREN, N.J., May 2, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: RBC Capital Markets 2024
PR NewswireMay 2 20:00
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Yahoo FinanceMay 1 00:25
Morgan Stanley Upgrades PTC Therapeutics to Equal-Weight, Raises Price Target to $30
Morgan Stanley analyst Jeffrey Hung upgrades PTC Therapeutics from Underweight to Equal-Weight and raises the price target from $28 to $30.
Analyst UpgradesApr 29 17:11
PTC Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 4.53% Morgan Stanley $28 → $30 Upgrades Underweight → Equal-Weight 04/12/2024 56.79% Cantor Fit
BenzingaApr 29 17:09
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts
Yahoo FinanceApr 28 21:14
PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceApr 27 21:12
No Data
No Data